Mangoceuticals, Inc. (MGRX)

Mangoceuticals Statistics

Total Valuation

Mangoceuticals has a market cap or net worth of $16.27 million. The enterprise value is $15.90 million.

Market Cap	16.27M
Enterprise Value	15.90M

Important Dates

The last earnings date was Friday, November 14, 2025, after market close.

Earnings Date	Nov 14, 2025
Ex-Dividend Date	n/a

Share Statistics

Mangoceuticals has 13.91 million shares outstanding. The number of shares has increased by 334.64% in one year.

Current Share Class	13.91M
Shares Outstanding	13.91M
Shares Change (YoY)	+334.64%
Shares Change (QoQ)	+15.43%
Owned by Insiders (%)	20.07%
Owned by Institutions (%)	2.69%
Float	10.15M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	18.91
Forward PS	n/a
PB Ratio	1.09
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	34.06
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.74, with a Debt / Equity ratio of 0.01.

Current Ratio	0.74
Quick Ratio	0.60
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -136.16% and return on invested capital (ROIC) is -78.35%.

Return on Equity (ROE)	-136.16%
Return on Assets (ROA)	-73.78%
Return on Invested Capital (ROIC)	-78.35%
Return on Capital Employed (ROCE)	-117.56%
Revenue Per Employee	$155,636
Profits Per Employee	-$6.92M
Employee Count	3
Asset Turnover	0.03
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -52.63% in the last 52 weeks. The beta is 2.39, so Mangoceuticals's price volatility has been higher than the market average.

Beta (5Y)	2.39
52-Week Price Change	-52.63%
50-Day Moving Average	1.90
200-Day Moving Average	2.17
Relative Strength Index (RSI)	40.04
Average Volume (20 Days)	3,962,258

Short Selling Information

The latest short interest is 1.86 million, so 13.37% of the outstanding shares have been sold short.

Short Interest	1.86M
Short Previous Month	128,445
Short % of Shares Out	13.37%
Short % of Float	18.32%
Short Ratio (days to cover)	0.57

Income Statement

In the last 12 months, Mangoceuticals had revenue of $466,908 and -$20.77 million in losses. Loss per share was -$2.89.

Revenue	466,908
Gross Profit	283,014
Operating Income	-18.49M
Pretax Income	-19.82M
Net Income	-20.77M
EBITDA	-16.49M
EBIT	-18.49M
Loss Per Share	-$2.89

Balance Sheet

The company has $481,281 in cash and $112,167 in debt, giving a net cash position of $369,114 or $0.03 per share.

Cash & Cash Equivalents	481,281
Total Debt	112,167
Net Cash	369,114
Net Cash Per Share	$0.03
Equity (Book Value)	15.73M
Book Value Per Share	1.13
Working Capital	-206,052

Cash Flow

Operating Cash Flow	-5.90M
Capital Expenditures	n/a
Free Cash Flow	-5.90M
FCF Per Share	-$0.42

Margins

Gross Margin	60.61%
Operating Margin	-3,960.04%
Pretax Margin	-4,245.52%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Mangoceuticals does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-334.64%
Shareholder Yield	-334.64%
Earnings Yield	-127.68%
FCF Yield	-36.27%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on October 16, 2024. It was a reverse split with a ratio of 1:15.

Last Split Date	Oct 16, 2024
Split Type	Reverse
Split Ratio	1:15

Scores

Mangoceuticals has an Altman Z-Score of 4.34 and a Piotroski F-Score of 3.

Altman Z-Score	4.34
Piotroski F-Score	3